Bill Snyder Archive — Page 67 of 119

March 15, 2018

Volunteers sought for bird flu vaccine trial

Vanderbilt University Medical Center is recruiting volunteers to participate in a national study of an investigational vaccine against the H7N9 influenza virus, also known as “bird flu.”

March 15, 2018

MIT’s Wittrup set for March 22 Flexner Discovery Lecture

K. Dane Wittrup, PhD, a pioneer in protein engineering technologies who has helped accelerate development of antibody therapies for cancer, will deliver the next Flexner Discovery Lecture on Thursday, March 22.

close up of mans arm as he receives chemotherapy infusion
March 14, 2018

Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer

New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.

ekg results
March 12, 2018

Long QT syndrome – revealed

Vanderbilt investigators have used sophisticated cell biological and structural techniques to “classify” mutations in potassium channels, studies that could lead to personalized treatment of heart rhythm disorders.

March 6, 2018

Discovery by Vanderbilt-led group could lead to improved diabetes treatment

Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D).

neuron
March 1, 2018

Graphene material strengthens nerve signaling in the brain

Less than 20 years after it was developed, a thin, resilient sheet of carbon atoms with remarkable properties known as graphene is transforming biomedical fields as far flung as tissue engineering, neuroprosthetics and drug discovery.